CDKN2C Protéine

N° du produit ABIN7938744

Cette protéine Recombinant CDKN2C est exprimée dans Escherichia coli (E. coli).

Aperçu rapide pour CDKN2C Protéine (ABIN7938744)

Antigène: CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))

Type de proteíne: Recombinant

Origine: Humain

Source: Escherichia coli (E. coli)

Application: Activity Assay (AcA), Functional Studies (Func), Screening Assay (ScA)

Détail du produit

Fonction: Recombinant CDKN2C protein

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Recombinant CDKN2C protein is supplied in 25 mM Tris pH 7.4, 300 mM NaCl, 10 % glycerol, 0.5 mM TCEP.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles,keep on ice when not in storage

Stock: -80 °C

Stockage commentaire: Recombinant proteins in solution are temperature sensitive and must be stored at -80°C to prevent degradation. Avoid repeated freeze/thaw cycles and keep on ice when not in storage.

Détail du antigène

Antigène: CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))

Autre désignation: CDKN2C

Sujet:

Protein Background: CDKN2C (Cyclin-dependent kinase 4 inhibitor C,also known as Cyclin-dependent kinase 6 inhibitor,p18- INK4c or p18-INK6) is a cyclin kinase inhibitors. Cell cycle regulatory proteins play a critical role in both normal cell growth and tumorigenesis, and the cyclin dependent kinases (CDKs) are the principle regulators of cell cycle progression , and thus are important candidates for therapeutic tumour suppressors. The CDKs, which are responsible for the phosphorylation of the retinoblastoma protein (pRb) and pRb related proteins, are in turn regulated by changes in cyclin levels, phosphorylation and the presence of cyclin kinase inhibitors (CKIs). Two classes of CKIs are present within mammalian cells . One class, the p21 family, consists of p21CIP1/WAF1, p27KIP1 and p57KIP2 which are general inhibitors of the G1S CDKs. Homology between family members is limited to a conserved amino-terminal 60-residue domain responsible for kinase binding and inhibition. The second class of CKIs, the INK4 (Inhibitor of CDK4) family is a group of ankyrin repeat proteins whose members p16INK4a, p15INK4b, p18INK4c and p19INK4d are specific inhibitors of cyclin D1/CDK4 or CDK6 complexes.CDKN2C/p18INK4c as a cyclin kinase inhibitors,Interacts strongly with CDK6, weakly with CDK4. Inhibits cell growth and proliferation with a correlated dependence on endogenous retinoblastoma protein RB.

Short Description: Recombinant CDKN2C protein was expressed in E.colias the full length protein (accession number NP_001253.1) with an N-terminal 6xHis tag. The molecular weight of the protein is 20.06 kDa.

Aliases: Cyclin-dependent kinase 4 inhibitor C,also known as Cyclin-dependent kinase 6 inhibitor,p18- INK4c or p18-INK6

Pathways: Cycle Cellulaire, Mitotic G1-G1/S Phases